stars 1 stars 2 stars 3

KEDPLASMA specializes in the collection of high-quality plasma that is processed into plasma-based therapies to respond to patients’ needs the world over. KEDPLASMA is a subsidiary of Kedrion Biopharma, an international company that produces and distributes plasma-derived medicinal products for use in treating serious disorders such as hemophilia and immune system deficiencies. KEDPLASMA owns collection centers in the US. Plasma cannot be produced artificially. It is obtained only through the generosity of donors - volunteers who contribute a precious donation to others. KEDPLASMA seeks to increase donor participation by making donation easy, comfortable and safe and by educating donors about how their donations help Keep Life Flowing. Find out more at: kedrion.com kedplasma.us

KEDPLASMA Questions

The KEDPLASMA annual revenue was $26.7 million in 2026.

Matteo Cosimini is the Strategy and Business Development Director of KEDPLASMA.

326 people are employed at KEDPLASMA.

KEDPLASMA is based in Fort Lee, New Jersey.

The NAICS codes for KEDPLASMA are [32541, 3254, 325, 32].

The SIC codes for KEDPLASMA are [283, 28].

Top KEDPLASMA Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users